Before COVID, Moderna was a startup which had never brought a therapy to market. They've managed to stay independent, instead of a marriage to one of the giants like BioNTech has. As such, Moderna's production capacity was almost entirely funded by the US via OWS contracts - so until those orders are fulfilled, almost all Moderna doses have to go to the US, and even after that Pfizer has much larger global production capacity.